A fee-shifting order in the Gilead Sciences Inc. case doesn’t change Delaware’s Section 220 law—which governs how and when corporate books and records must be subject to inspection—but its the latest Chancery Court pronouncement is part of a gradual definition of hazy boundaries in a form of litigation that’s become increasingly prevalent.

Chancellor Kathaleen McCormick’s decision in July to require the Bay Area maker of an HIV drug to pay $1.7 million in shareholders’ attorney fees due to its “glaringly egregious” legal tactics is the first to hold a corporate defendant financially liable for the cost of Section 220 litigation and the latest of several in the past year that have fallen in shareholders’ favor and resulted in corporations being ordered to hand over books and records.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]